🇺🇸#акции #сша #premarket
премаркет США - акции - заметные движения:
ВВЕРХ
#OASM +64% Oasmia Pharmaceutical AB - after Oasmia and Arwidsro solved outstanding balances. Arwidsro increaseD its investment in Oasmia.
#DBVT +22% DBV Technologies S.A. - after gaining 8% on Wednesday.
#MAXR +9% Maxar Technologies Inc..
#VERU +8% Veru Inc.
#KPTI +6% Karyopharm Therapeutics Inc. - on continued strength after the company on Wednesday announced FDA approval of XPOVIO for treatment of patients with relapsed, refractory multiple myeloma.
#FSM +6% Fortuna Silver Mines Inc.
#MRNA +5% Moderna, Inc.
#BGS +4% B&G Foods, Inc.
#AYX +4% Alteryx, Inc.
#NIO +4% NIO Inc. - after gaining 10% on Wednesday.
#FANG +4% Diamondback Energy, Inc.
#GRFS +3% Grifols, S.A. - after the company reported the FDA approval of Xembify, its new 20% subcutaneous immunoglobulin for treating primary immunodeficiencies.
ВНИЗ
#MLNT -13% Melinta Therapeutics, Inc. -after rising 17% on Wednesday.
#MTC -8% Mmtec, Inc.
#RBZ -8% Reebonz Holding Limited - after dropping 5% on Wednesday.
#FATE -7% Fate Therapeutics, Inc. - after gaining 6% on Wednesday.
#AB -5% AllianceBernstein Holding L.P.
#CYAD -5% Celyad SA - after the company issued update on autologous & allogeneic NKG2D-based CAR-T therapies in solid tumors.
#RIO -5% Rio Tinto Group
#BBL -5% BHP Group
#TTMI -4% TTM Technologies, Inc.
премаркет США - акции - заметные движения:
ВВЕРХ
#OASM +64% Oasmia Pharmaceutical AB - after Oasmia and Arwidsro solved outstanding balances. Arwidsro increaseD its investment in Oasmia.
#DBVT +22% DBV Technologies S.A. - after gaining 8% on Wednesday.
#MAXR +9% Maxar Technologies Inc..
#VERU +8% Veru Inc.
#KPTI +6% Karyopharm Therapeutics Inc. - on continued strength after the company on Wednesday announced FDA approval of XPOVIO for treatment of patients with relapsed, refractory multiple myeloma.
#FSM +6% Fortuna Silver Mines Inc.
#MRNA +5% Moderna, Inc.
#BGS +4% B&G Foods, Inc.
#AYX +4% Alteryx, Inc.
#NIO +4% NIO Inc. - after gaining 10% on Wednesday.
#FANG +4% Diamondback Energy, Inc.
#GRFS +3% Grifols, S.A. - after the company reported the FDA approval of Xembify, its new 20% subcutaneous immunoglobulin for treating primary immunodeficiencies.
ВНИЗ
#MLNT -13% Melinta Therapeutics, Inc. -after rising 17% on Wednesday.
#MTC -8% Mmtec, Inc.
#RBZ -8% Reebonz Holding Limited - after dropping 5% on Wednesday.
#FATE -7% Fate Therapeutics, Inc. - after gaining 6% on Wednesday.
#AB -5% AllianceBernstein Holding L.P.
#CYAD -5% Celyad SA - after the company issued update on autologous & allogeneic NKG2D-based CAR-T therapies in solid tumors.
#RIO -5% Rio Tinto Group
#BBL -5% BHP Group
#TTMI -4% TTM Technologies, Inc.